Pharmafile Logo
Pharmafocus logo
Advanced Search
madrid_-_johnson__johnson_1

Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion

August 20, 2020
Business Services, Sales and Marketing Johnson and Johnson, Momenta

Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …

News
450px-official_portrait_of_owen_smith_crop_2_1

Former MP and Labour leadership candidate joins Bristol Myers Squibb

August 20, 2020
Business Services Big Pharma, Pfizer

Owen Smith, the former Labour MP and leadership candidate, has joined Bristol Myers Squibb as its UK Government Relations Director. Smith …

News
merckincweb2

MSD unveils plans for $1.3bn central London research centre

August 19, 2020
Manufacturing and Production, Research and Development London, MSD, pharma

MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …

News
sydney

Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate

August 19, 2020
Research and Development AstraZeneca, Australia, COVID-19, pharma

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …

News
800px-temazepam_10mg_tablets-1

US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation

August 19, 2020
Research and Development opioid crisis, opioid epidemic, opioids

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major …

News
bojo

UK Government officially announces National Institute for Health Protection to replace Public Health England

August 19, 2020
Research and Development opioid, opioid crisis, opioid epidemic

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection. …

News
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

August 19, 2020
Research and Development coronavirus, top 10

Potentially unsafe coronavirus treatments are in the headlines this week, as President Donald Trump reportedly wants to approve Phoenix Biotechnology’s …

News
fda

Poseida suspends CAR T therapy trial in prostate cancer due to patient death

August 18, 2020
Manufacturing and Production, Research and Development CAR T, CAR-T, Poseida, patient death, pharma

Poseida’s Phase 1 trial that used an investigational CAR T therapy for treating prostate cancer has been suspended due to …

News
shutterstock_273326141

Bristol Myers Squibb pays $475 million for exclusive rights to Dragonfly Therapeutics’ IL-12 immunotherapy programme

August 18, 2020
Manufacturing and Production, Sales and Marketing Bristol Myers Squib, Drgonfly Therapeutics, pharma, pharma deal

Bristol Myers Squibb has scooped up the sole rights to the interleukin-12 (IL-12) immunotherapy programme of Massachusetts-based biotech Dragonfly Therapeutics, …

News
trummmuuuue

Trump allegedly “enthusiastic” for oleandrin to be approved as a COVID-19 treatment

August 18, 2020
Manufacturing and Production, Research and Development coronavirus vaccine, covid19

President Donald Trump reportedly wants to approve Phoenix Biotechnology’s oleandrin as a coronavirus treatment, despite a lack of evidence for …

News
shutterstock_36423250

China approves its first biosimilar of Roche’s Herceptin in HER2+ cancers

August 18, 2020
Manufacturing and Production, Sales and Marketing China, Henlius, Herceptin, Roche, biosimilar

China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …

News
cbdx

NHS guidelines on prescription cannabis to be challenged in court

August 18, 2020
Manufacturing and Production, Research and Development CBD, cannabis, epilepsy

The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …

News
transportation_isolation_system

China’s drug regulator says vaccines must have 50 percent efficacy to be approved

August 17, 2020
Sales and Marketing COVID, China, coronavirus, vaccines

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved.  …

News
cokc

Public Health England set to be replaced by a new agency to specifically deal with pandemics

August 17, 2020
Sales and Marketing COVID, Public Health England, pandemic, phe

Public Health England is set to be replaced with a new agency to prepare the country to deal with future …

News
23814734268_1b63909bf3_z

Amazon Pharmacy launches in India

August 17, 2020
Sales and Marketing India, amazon, pharma

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. 

News
6127242068_23c80ef94f_b

Sanofi to buy Principia Biopharma for $3.4 billion

August 17, 2020
Sales and Marketing MS, Sanofi

Sanofi is set to buy California based Principia Biopharma in a deal that is worth $3.4 billion. This deal means …

News
fda_23

FDA approves Roche’s Enspryng for neuromyelitis optica

August 17, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …

News
fda2outsideweb

FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

August 14, 2020
Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …

News
fillip

Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine

August 14, 2020
Medical Communications COVID, COVID-19, coronavirus, vaccines

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …

News
shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026